Back to search

University of Patras

Μελέτη της αποτελεσματικότητας 3 τύπων επεμβάσεων για την αντιμετώπιση της κλινικά σοβαρής παχυσαρκίας: της γαστρικής παράκαμψης μίας αναστόμωσης, της τυπικής γαστρικής παράκαμψης Roux-en-Y και της χολοπαγκρεατικής εκτροπής

Abstract

dc:description

The present study is a retrospective analysis of prospectively collected data (from the database of Morbid Obesity Unit at Patras University Hospital), from a case - matched non - superobese population of patients treated for obesity with three different procedures: one anastomosis gastric bypass (OAGB), standard Roux-en-Y gastric bypass (RYGB) and a variant of biliopancreatic diversion (BPD-LL). Bariatric outcomes, non-metabolic complications and postoperative metabolic parameters were followed until the 6th postoperative year.Thirty four patients from each group were included in the study. The average patient age was 37.4 years (range 19 - 57), 85.3% female and 14.7% male, with a mean body mass index (BMI) of 46.3 kg/m2 (range 38.3 - 49.7). There was a consistent 88% - 100% follow-up rate up until the fourth postoperative year, while approximately, 73.5%, 52.9% and 70.6% of patients who underwent RYGB, OAGB and BPD-LL respectively were evaluated at the 6-year follow-up visit.No deaths or major non-metabolic complications were recorded during the 6-year follow-up period. No differences were observed regarding renal function, most electrolytes (Na, K, Mg, P) and B12 vitamin.Patients in the OAGB group had consistently statistically significant lower calcium levels and more cases of hypocalcemia (23.5% vs 8.8%) than patients in the RYGB group. Moreover, OAGB patients had significantly lower calcium levels in the long term compared to BPD-LL, even though the mean values remained within normal range. With sufficient postoperative calcium and vitamin D3 supplementation, RYGB patients may have even better calcium levels than preoperatively. The same doses are insufficient for the two more malabsorptive procedures. Despite routine calcium and vitamin D3 supplementation, mean levels of PTH increased from their baseline for all bariatric procedures, albeit remained also within normal range. Secondary hyperparathyroidism (SHPT), defined as PTH > 65 mg/ml, was present preoperatively in 14.7% of patients in RYGB and BPD-LL groups and in 21.9% of patients in the OAGB group. The prevalence of SHPT decreased in the RYGB and BPD-LL groups for the first two postoperative years; for OAGB decrease was observed only the first postoperative year. After that, there was a gradual increase for all three groups, reaching even 68% for OAGB at the sixth year of follow-up. The deference was constantly significant only between OAGB and the other two groups, even though BPD-LL is a more malabsorptive procedure than RYGB.Among women, there were no statistically significant differences of mean hemoglobin (Hb) levels between the groups at any time of the follow-up. However, the range of Hb levels within each group was consistently wide. As a result, anemia - as defined as Hb < 12 gr/dl - was present preoperatively in 17.2% of women in RYGB and OAGB groups and in 13.8% in the BPD-LL group. The prevalence of anemia for the RGYB group reached 14.8% at 1 year, 25% at 2 years, 25.9% at 3 years, 34.5% at 4 years, 19% at 5 years and 39.1% at 6 years. For the OAGB group the prevalence was 28.6% at 1 year, 44.4% at 2 years, 42.3% at 3 years, 55.2% at 4 years, 45.8% at 5 years and 53.3% at 6 years, while for the BPD-LL group was 31% at 1 year, 39.3% at 2 years, 56% at 3 years, 55.2% at 4 years, 52.9% at 5 years and 57.9% at 6 years. These differences were significant for the first 5 years of the follow-up between RYBG and the other two groups. There was one case in each of the OAGB and BPD-LL groups that required administration of intravenous iron. The small numbers of men in the cohort does not provide enough data for comparisons.Mean albumin levels in BPD-LL group were significantly lower than in the other groups at the 4 year of follow-up. Hypoalbuminemia - as defined as albumin < 3.5 g/dl - was more frequently present in the RYGB (3.2% at 1 year, 3.0% at 2 years, 6.3% at 3 years and 4.3% at 5 years) and BPD-LL (2.9% at 1 year, 3.0% at 2 years and 5.9% at 3 years) groups than in the OAGB group (2.9% at 4 years and 3.3% at 5 years). In any case, the deficiency was mild with the lowest value of albumin recorded being 3.1 gr/dl. No patient required revision of the operation or total parenteral nutrition, and after nutritional counseling, hypoalbuminemia did not recur.Mean excess weight loss (EWL%) was 70.1% at 1 year, 72.3% at 2 years, 64.9% at 3 years, 64.2% at 4 years, 63.2% at 5 years and 63.8% at 6 years for the RYGB group, 80.4% at 1 year, 82.6% at 2 years, 76.6% at 3 years, 74.5% at 4 years, 73.6% at 5 years and 68.0% at 6 years for the OAGB group, and 80.9% at 1 year, 85.3% at 2 years, 83.6% at 3 years, 79.9% at 4 years, 73.8% at 5 years and 76.3% at 6 years for the BPD-LL group. Mean EWL% was always significantly greater, and postoperative BMI was significantly lower after OAGB or BPD-LL compared to RYGB during the first 4 years. On subsequent years this effect was still evident, but not statistically significant.There was a considerable weight loss failure rate in the RYGB group, which was evident even from the first postoperative year and significant after the third year. The failure rate for RYGB group was 3.2% at 1 year, 6.1% at 2 years, 21.9% at 3 years, 23.5% at 4 years, 26.1% at 5 years and 16.0% at 6 years. Among the patients of the OAGB group, failure was recorded at 3.2% at 3 years, 8.8% at 4 years, 6.7% at 5 years and 11.1% at 6 years, while among the BPD-LL group the failures were observed only at 14.3% of the patients at 5 years.Comorbidities were successfully encountered with all procedures at comparable rates. However, OAGB offered better overall glycaemic control and lower HbA1c levels than RYGB and comparable results to BPD-LL (5.0% vs 5.4% vs 5.4% at 1 year, 5.0% vs 5.3% vs 4.8% at 2 years, 5.4% vs 5.5% vs 4.9% at 3 years, 5.2% vs 5.6% vs 5.2% at 4 years, 5.2% vs 5.6% vs 5.0% at 5 years, 5.4% vs 5.4% vs 5.5% at 6 years, respectively), even though in OAGB group the preoperative diabetes control was poorer (preoperative HbA1c: RYGB: 6.6% - OAGB: 7.7% - BPD-LL: 7.5%).As a conclusion, regarding weight loss and glycaemic control, OAGB had comparable results to BPD-LL and was significantly better than RYGB. Safety profile was analogous to RYGB, with the exception of calcium levels, which, even thought were within normal range, were significantly lower than those in RYGB. OAGB offered comparable mid-term results as BPD-LL, while being safe and with minimal impact on patients’ nutritional state. It is an effective procedure for treating morbid obesity, which results in sustained weight loss and high rate of resolution of comorbidities.

Degree

thesis:*
Grantor dc:publisher
University of Patras
Year dc:date
2021

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Markopoulos, Georgios
  • Μαρκόπουλος, Γεώργιος

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/50463

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Markopoulos, Georgios; Μαρκόπουλος, Γεώργιος. Μελέτη της αποτελεσματικότητας 3 τύπων επεμβάσεων για την αντιμετώπιση της κλινικά σοβαρής παχυσαρκίας: της γαστρικής παράκαμψης μίας αναστόμωσης, της τυπικής γαστρικής παράκαμψης Roux-en-Y και της χολοπαγκρεατικής εκτροπής. University of Patras, 2021. http://hdl.handle.net/10442/hedi/50463